Document
type: Class

1218340
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: HSV-TK engineered donor lymphocytes add-backs reduce late mortality and improve survival of high risk acute leukemia after haplo-HSCT: Results of a phase II multicenter trial.

1218341
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: HSV-TK engineered donor lymphocytes add-backs reduce late mortality and improve survival of high risk acute leukemia after haplo-HSCT: Results of a phase II multicenter trial.

Continuant
type: Class

Abstract
type: Class

Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-24T02:04:33
publisher: HSV-TK engineered donor lymphocytes add-backs reduce late mortality and improve survival of high risk acute leukemia after haplo-HSCT: Results of a phase II multicenter trial.
type: Document
label: RDF description of HSV-TK engineered donor lymphocytes add-backs reduce late mortality and improve survival of high risk acute leukemia after haplo-HSCT: Results of a phase II multicenter trial. - http://irises.unisr.it/resource/item/16362

HSV-TK engineered donor lymphocytes add-backs reduce late mortality and improve survival of high risk acute leukemia after haplo-HSCT: Results of a phase II multicenter trial.
type: Thing
language: Inglese
type: Document
most specific type: Abstract
type: Abstract
related by: 1218341
type: Generically Dependent Continuant
type: Information Content Entity
type: Entity
type: Continuant
related by: 1218340

Generically Dependent Continuant
type: Class

Inglese
type: Language

Information Content Entity
type: Class